EditorialPublished 8 May 2020

Glioblastoma Multiforme and its Cell Incursion; an Expert Opinion

Authors: Sankha Bhattacharya

European Journal of Clinical Oncology

Volume 2 · Issue 1 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Glioblastoma (GBM) is a fatal type of brain cancer or primary glial neoplasm, mostly targeting aged populations. The average survival is only 15 mouths from the date of occurrence. It is often observed, the invasive nature of tumour is the main reason for poor prognosis and strong recurrence of GBM in patients even after prescribed treatments. Despite all type of therapy, it is necessary to understand the various molecular mechanisms and signalling pathways to identify targets for GBM treatment. This compilation is specifically design to discuss about Wnt signalling and Hedgehog-GLI1 pathways which have positive and negative regulation against GBM. The recent research finding associated with different signalling pathways for GBM was also been discussed within this article.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in European Journal of Clinical Oncology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEuropean Journal of Clinical Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Sankha Bhattacharya”